Valeurs | |||||
Le rangement donne un aperçu de toutes les valeurs mobilières classées de manière alphabétique ou selon les indices. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Nom | Code | Analysis date | Cours de clôture | +/- % |
O-I Glass | OI | 4. nov 2024 | 11.35 | +0.98 |
Oak Valley Bancorp | OVLY | 4. nov 2024 | 27.19 | +0.11 |
Oak Woods Acquisition | OAKU | 4. nov 2024 | 11.21 | 0.00 |
Oaktree Acquisition III Life Sciences Unit | OACCU | 4. nov 2024 | 10.02 | 0.00 |
Oaktree Capital A Pref | OAK-A | 4. nov 2024 | 23.77 | -0.28 |
Oaktree Capital Group B Pref | OAK-B | 4. nov 2024 | 22.93 | -0.78 |
Oaktree Specialty | OCSL | 4. nov 2024 | 15.59 | -2.32 |
Oatly ADR | OTLY | 4. nov 2024 | 0.81 | +0.74 |
Oblong | OBLG | 4. nov 2024 | 3.67 | -1.08 |
Occidental Petroleum | OXY | 4. nov 2024 | 50.56 | +2.00 |
Ocean Biomedical | OCEA | 4. nov 2024 | 0.90 | +1.16 |
Ocean Power Technologies | OPTT | 4. nov 2024 | 0.15 | +2.29 |
Oceaneering International | OII | 4. nov 2024 | 25.45 | +4.13 |
OceanFirst Financial | OCFC | 4. nov 2024 | 17.73 | -2.58 |
OceanFirst Pref | OCFCP | 4. nov 2024 | 24.90 | -0.24 |
OceanPal | OP | 4. nov 2024 | 1.50 | -7.87 |
Ocugen | OCGN | 4. nov 2024 | 0.96 | +0.86 |
Ocular Therapeutix | OCUL | 4. nov 2024 | 10.27 | -1.16 |
Oculis | OCS | 4. nov 2024 | 17.59 | -1.62 |
Ocuphire Pharma | OCUP | 4. nov 2024 | 1.17 | 0.00 |
Oddity Tech | ODD | 4. nov 2024 | 39.92 | +4.86 |
Odyssey Marine Exploration | OMEX | 4. nov 2024 | 0.52 | +0.98 |
Offerpad Solutions A | OPAD | 4. nov 2024 | 3.27 | +4.81 |
Office Properties | OPI | 4. nov 2024 | 1.42 | -5.33 |
OFG Bancorp | OFG | 4. nov 2024 | 40.46 | -0.86 |
OFS Capital | OFS | 4. nov 2024 | 7.95 | -1.49 |
OFS Credit | OCCI | 4. nov 2024 | 7.04 | +0.43 |
OFS Credit C Pref | OCCIO | 4. nov 2024 | 24.89 | 0.00 |
OFS Credit Company Pref F | OCCIM | 4. nov 2024 | 24.98 | 0.00 |
OFS Credit E Pref | OCCIN | 4. nov 2024 | 23.76 | 0.00 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.